![]() Tollys Tollys is a biopharmaceutical company focused on innate immunity, particularly on the biology and modulation of the TLR3 receptor. | |||
Founding Date | Founding Date 2014 | Founding Date 2008 | Founding Date 2015 |
Type | Type Private | Type Private | Type Private |
Tags | |||
Locations | Locations Singapore, SG HQ Houston, US South San Francisco, US | Locations Yantai, CN HQ | Locations Lyon, FR HQ Lyon, FR |
Employees | Employees 731% decrease | Employees 1401% decrease | Employees N/A |
Funding | |||
Latest funding round | Latest funding round $ 125m (about 5 years ago) | Latest funding round $ 100m (about 6 years ago) | Latest funding round $ 2.5m (about 6 years ago) |
Total funding raised | Total funding raised $ 190m | Total funding raised $ 100m | Total funding raised $ 6.8m |

Remegen is a company that develops biopharmaceutical products.
View company
Tollys is a biopharmaceutical company focused on innate immunity, particularly on the biology and modulation of the TLR3 receptor.
View company